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Abstract
Purpose: We reviewed 19 studies of mammals fed with commercialized genetically modified soybean and maize
which represent, per trait and plant, more than 80% of all environmental genetically modified organisms (GMOs)
cultivated on a large scale, after they were modified to tolerate or produce a pesticide. We have also obtained the
raw data of 90-day-long rat tests following court actions or official requests. The data obtained include biochemical
blood and urine parameters of mammals eating GMOs with numerous organ weights and histopathology findings.
Methods: We have thoroughly reviewed these tests from a statistical and a biological point of view. Some of
these tests used controversial protocols which are discussed and statistically significant results that were considered
as not being biologically meaningful by regulatory authorities, thus raising the question of their interpretations.
Results: Several convergent data appear to indicate liver and kidney problems as end points of GMO diet effects
in the above-mentioned experiments. This was confirmed by our meta-analysis of all the in vivo studies published,
which revealed that the kidneys were particularly affected, concentrating 43.5% of all disrupted parameters in
males, whereas the liver was more specifically disrupted in females (30.8% of all disrupted parameters).
Conclusions: The 90-day-long tests are insufficient to evaluate chronic toxicity, and the signs highlighted in the
kidneys and livers could be the onset of chronic diseases. However, no minimal length for the tests is yet
obligatory for any of the GMOs cultivated on a large scale, and this is socially unacceptable in terms of consumer
health protection. We are suggesting that the studies should be improved and prolonged, as well as being made
compulsory, and that the sexual hormones should be assessed too, and moreover, reproductive and
multigenerational studies ought to be conducted too.
Background, aim, and scope
Recently, an ongoing debate on international regulation
has been taking place on the capacity to predict and
avoid adverse effects on health and the environment for
new products and novel food/feed (GMOs, chemicals,
pesticides, nanoparticles, etc.). The health risk assess-
ments are often, but not always, based on the study of
blood analyses of mammals eating these products in sub-
chronic tests, and more rarely in chronic tests. In particu-
lar, in the case of GMOs, the number and nature of
parameters assessed, the length of the necessary tests, the
statistics used and their interpretations are the subject of
controversies, especially in the application of Organiza-
tion of Economic Cooperation and Development (OECD)
norms. Confusion is perceived even in regulatory agen-
cies, as in the European Food Safety Authority (EFSA)
GMO panel working group and its guidelines. Doubt has
arisen on the role and necessity of animal feeding trials
in safety and nutritional assessments of GM plants and
derived food and feed [1]. Based on the literature data,
EFSA first admitted (p. S33) that for other tests than
GMOs: “For 70% (57 of 81) of the studies evaluated,
all toxicological findings in the 2-year tests were seen in
or predicted by the 3-month subchronic tests”. Moreover,
they also indicated (p. S60) that “to detect effects on
reproduction or development [...] testing of the whole
food and feed beyond a 90-day rodent feeding study may
be needed.” We fully agree with these assumptions. This
is why we think that in order to protect large populations
from unintended effects of novel food or feed, imported
or cultivated crops on a large scale, chronic 2-year
and reproductive and developmental tests are crucial.
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However, they have never been requested by EFSA for
commercial edible crops. We therefore wish to underline
that in contrast with the statements of EFSA, all com-
mercialized GMOs have indeed been released without
such tests being carried out, and as it was the case
recently with maize stacked events without 90-day in
vivo mammalian tests being conducted. GM stacked
events have the cumulated characteristics of first genera-
tion of GMOs (herbicide tolerance and insecticide pro-
duction), which are mostly obtained by hybridization. For
instance, Smarstax maize contains two genes for herbi-
cide tolerance and six genes for insecticide production.
In fact, this contradictory possibility was already high-
lighted in the same review by EFSA (p. S60), when sub-
stantial equivalence studies and other analyses were
performed: “animal feeding trials with rodents [...] adds
little if anything [...], and is not recommended.” This is
why, in this work we will analyze and review deficiencies
in GMO safety assessments, not only performed by bio-
tech companies, but also by regulatory agencies.
We will focus on the results of available 90-day feed-
ing trials (or more) with commercialized GMOs, in the
light of modern scientific knowledge. We also suggest
here an alternative to conventional feeding trials, to
understand the biological significance of statistical dif-
ferences. This approach will make it possible to avoid
both false negative and false positive results in order to
improve safety assessments of agricultural GMOs before
their commercialization for cultivation and food/feed
use and imports.
Overview of the safety studies of GMOs performed on
mammals
Our experience in scientific committees for the assess-
ment of environmental and health risks of GMOs and
in biological, biostatistical research, and medicine, as
well as in the research relative to side effects [2-6]
allowed us to review and criticize mammalian feeding
trials with GMOs and make new proposals. Mammalian
feeding trials have been usually but not always per-
formed for regulatory purposes in order to obtain
authorizations or commercialization for GM plant-
derived foods or feed. They may have been published in
the scientific literature afterwards; however, without
public access to the raw data.
We have obtained, following court actions or official
requests, the raw data of several 28- or 90-day-long safety
tests carried out on rats. The thing we did was to thor-
oughly review the longest tests from both a biostatistical
and a biological point of view. Such studies often analyze
the biochemical blood and urine parameters of mammals
eating GMOs, together with numerous organ weights
and histopathology. We have focused our review on com-
mercialized GMOs which have been cultivated in
significant amounts throughout the world since 1994
(Table 1). We observe and emphasize that all the events
in Table 1 correspond to soybean and maize which con-
stitute 83% of the commercialized GMOs, whilst other
GMOs not displayed in the table, but still commercia-
lized, are canola or cotton. However, they are not usually
directly consumed [7]. Only Sakamoto’s and Malatesta’s
studies have been more than 90 days long (104 weeks
and 240 days with blood analyses in Japanese for the first
one). Moreover, such tests are not obligatory yet for all
GMOs. No detailed blood analysis is available for Mala-
testa’s study, as it mostly includes histochemistry at the
ultrastructural level; moreover, the latter tests have not
been used to obtain the commercial release by the firm.
However, this work has been performed by researchers
independent from the GMO industry; it is an important
element to take into account for an objective interpreta-
tion of the facts, as pointed out in the case of the risk
assessments conducted by regulatory agencies with
Bisphenol A. For instance in the latter case, it was
observed that none of the industry-funded studies
showed adverse effects of Bisphenol A, whereas 90% of
government-funded studies showed hazards at various
levels and various doses [8]. However, regulatory agencies
still continue to refer only to industry-funded studies
because they are supposed to follow OECD norms, even
if such standards are not always appropriate for the
detection of environmental hazards [9]. In this paper,
Myers et al. showed that hundreds of laboratory animals
and cell culture studies were rejected by regulatory
authorities because they did not follow the Good Labora-
tory Practices (GLP). The Food and Drug Administration
and EFSA have based their final decision on two indus-
try-funded studies, claiming that they were superior to
the others because they followed GLP. Yet, GLP are
based on ancient paradigms. They have serious concep-
tual and methodological flaws, and do not take into
account the latest knowledge in environmental sciences.
For example, in the case of Bisphenol A assessment, the
animal models used are known to be insensitive to estro-
gen (CD-1 mouse). Also, assays and protocols in some
OECD guidelines are out of date and insensitive. It is
obvious that new product assessments should be based
on adapted studies using state-of-the-art experiments.
The significant gap between scientific knowledge and
regulations should be filled also in the case of GMOs [9].
Therefore, some tests presented here show controversial
results or statistically significant results that were not
considered as biologically significant by EFSA, raising the
question of their interpretation.
First of all, the data indicating no biological signifi-
cance of statistical effects in comparison to controls
have been published mostly by companies from 2004
onwards, and at least 10 years after these GMOs were
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first commercialized round the world. This is a matter
of grave concern. Moreover, only three events were
tested for more than 90-days in feeding experiments or
on more than one generation. This method was not per-
formed by industries which conducted 90-day tests (with
blood and organ analyses), but it was in some cases
only. However, a 90-day period is considered as insuffi-
cient to evaluate chronic toxicity [1,5]. All these com-
mercialized cultivated GMOs have been modified to
contain pesticides, either through herbicide tolerance or
by producing insecticides, or both, and could therefore
be considered as “pesticide plants.” Almost all GMOs
only encode these two traits despite claims of numerous
other traits. For instance, Roundup ready crops have
been modified in order to become insensitive to glypho-
sate. This chemical together with adjuvants in formula-
tions constitutes a potent herbicide. It has been used for
many years as a weed killer by blocking aromatic amino
acid synthesis by inhibition of 5-enolpyruvylshikimate-3-
phosphate synthase (EPSPS). Most Roundup ready
plants have been modified thanks to the insertion of a
mutated EPSPS gene coding for a mutated enzyme,
which is not inhibited by glyphosate. Therefore, GM
plants exposed to glyphosate-based herbicides such as
Roundup do not specifically degrade glyphosate. They
can even accumulate Roundup residues throughout
their life, even if they excrete most of such residues.
Glyphosate and its main metabolite AMPA (with its
own toxicity) are found in GMOs on a regular and
regulatory basis [10,11]. Therefore, such residues are
absorbed by people eating most GM plants (as around
80% of these plants are Roundup tolerant). On the other
hand, about 20% of the other GMOs do synthesize new
insecticide proteins through the insertion of mutated
genes derived from Bacillus thuringiensis (Bt).
Usually, pesticides are tested over a period of 2 years
on a mammal, and this quite often highlights side
effects. Additionally, unintended effects of the genetic
modification itself cannot be excluded, as direct or
indirect consequences of insertional mutagenesis, creat-
ing possible unintended metabolic effects. For instance,
in the MON810 maize, the insertion of the transgene in
the ubiquitine ligase gene caused a complex recombina-
tion event, leading to the synthesis of new RNA pro-
ducts encoding unknown proteins [12]. Thus, genetic
modifications can induce global changes in the genomic,
transcriptomic, proteomic, or metabolomic profiles of
the host. The frequency of such events in comparison to
classical hybridization is by nature unpredictable. In
addition, in a plant producing a Cry1Ab-modified toxin,
a metabolomic study [13] revealed that the transgene
introduced indirectly 50% changes in osmolytes and
branched amino acids.
Review of statistical effects after GMO consumption
Some GMOs (Roundup tolerant and MON863) affect
the body weight increase at least in one sex [2,14]. It is
a parameter considered as a very good predictor of side
Table 1 Review of the longest chronic or subchronic toxicity studies in mammals fed with commercialized GM
soybean and maize representing more than 80% of edible GMOs (2010)
References Plant Pesticide contained Name of
event
Species Duration Main observations
[17,38,39,19,15] Soybean Roundup herbicide mCP4 EPSPS Mouse 240 days Ultrastructural histochemistry
disturbed
[14] Soybean Roundup herbicide mCP4 EPSPS Rat 91 days Weight problems
[40] Soybean Roundup herbicide Optimum GAT
DP-356Ø43-5
Rat 93 days Statistical differencesa
[41] Soybean Roundup herbicide Not precise Rat 104 weeks Statistical differencesa
[42] Maize Roundup herbicide Optimum GAT
DP-Ø9814Ø-6
Rat 91 days Statistical differencesa
[43,5] Maize Roundup herbicide NK603 Rat 90 days Controversial results
[44,5] Maize mCry1Ab insecticide MON810 Rat 90 days Controversial results
[25,2,4,5] Maize mCry3Bb1 insecticide MON863 Rat 90 days Controversial results






[45] Maize mCry1F insecticide - glufosinate ammonium-
based herbicide
DAS-Ø15Ø7-1 Rat 91 days Statistical differencesa
[46,47] Maize mCry34Ab1, mCry35Ab1 insecticides -
glufosinate ammonium-based herbicide
DAS-59122-7 Rat 90 days Statistical differencesa
[48] Maize mCry1F, mCry34Ab1, mCry35Ab1 insecticides
- glufosinate ammonium-based herbicide
DAS-Ø15Ø7-1
× DAS-59122-7
Rat 92 days Statistical differencesa
aStatistical differences are not biologically meaningful for the authors; however, this can be debated. Oilseed rape and cotton have been excluded because they
are not directly edible and not primarily grown for feed. This table includes authorized events for food and feed at least in the European Union and America.
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effects in various organs. Several convergent factors
appear to indicate liver and kidney problems as end
points of GMO diet effects in these experiments
[2,5,15,16]. This was confirmed by our meta-analysis of
all in vivo studies published on this particular topic
(Table 2). The kidneys are particularly affected, concen-
trating 42% of all parameters disrupted in males. How-
ever, other organs may be affected too, such as the
heart and spleen, or blood cells [5].
Liver parameters
For one of the longest independent tests performed, a
GM herbicide-tolerant soybean available on the market
was used to feed mice. It caused the development of
irregular hepatocyte nuclei, more nuclear pores, numer-
ous small fibrillar centers, and abundant dense fibrillar
components, indicating increased metabolic rates [17]. It
was hypothesized that the herbicide residues could be
responsible for that because this particular GM plant
can absorb the chemicals to which it was rendered tol-
erant. Such chemicals may be involved in the above-
mentioned pathological features. This became even
clearer when Roundup residues provoked similar fea-
tures in rat hepatic cells directly in vitro [18]. The
reversibility observed in some instances for these para-
meters in vivo [19] might be explained by the heteroge-
neity of the herbicide residues in the feed [20]. Anyway,
these are specific parameters of ultrastructural dysfunc-
tion, and the relevance is clear. The liver is reacting.
The Roundup residues have been also shown to be toxic
for human placental, embryonic, and umbilical cord
cells [21-23]. This was also the case for hepatic human
cell lines in a comparable manner, inducing nuclei and
membrane changes, apoptosis and necrosis [24].
The other major GMO trait has to do with the
mutated (mBt) insecticidal peptidic toxins produced by
transgenes in plants. In this case, some studies with
maize confirmed histopathological changes in the liver
and the kidneys of rats after GM feed consumption.
Such changes consist in congestion, cell nucleus border
changes, and severe granular degeneration in the liver
[16]. Similarly, in the MON810 studies, a significantly
lower albumin/globulin ratio indicated a change in
hepatic metabolism of 33% of GM-fed male rats
(according to EFSA opinion on MON810 and [5]).
Taken together, the results indicate potential adverse
effects in hepatic metabolism. The insecticide produced
by MON810 could also induce liver reactions, like many
other pesticides. Of course, the mCry1Ab and other
mBt (mutated Bt toxins derived from native Bacillus
thuringiensis toxins) in GMOs are proteic toxins; how-
ever, these are modified at the level of their amino acid
sequence by biotechnologies and introduced by artificial
vectors, thus these could be considered as xenobiotics
(i.e., a molecule foreign to life). The liver together with
the kidneys are the major reactive organs in case of
food chronic intoxication.
Kidney parameters
In the NK603 study, statistically significant strong urine
ionic disturbances and kidney markers could be
explained by renal leakage [5], which is well correlated
with the effects of glyphosate-based herbicides (like
Roundup) observed on embryonic kidney cells [23]. This
does not exclude metabolic effects indirectly due to
insertional mutagenesis linked to the plant transforma-
tion. Roundup adjuvants even stabilize glyphosate and
allow its penetration into cells, which in turn inhibit
estrogen synthesis as a side effect, cytochrome P450 aro-
matase inhibition [21]. This phenomenon changes the
androgen/estrogen ratio and may at least, in part,
explain differential impacts in both sexes.
Kidney dysfunctions are observed with mBt maize
producing mutated insecticides such as in MON863. For
instance, we quote the initial EFSA report: “Individual
kidney weights of male rats fed with the 33% MON863
diet were statistically significantly lower compared to
those of animals on control diets”, “small increases in
the incidences of focal inflammation and tubular regen-
erative changes in the kidneys of 33% MON863 males.”
This was confirmed by the company tests [25] and
another counter analysis revealed disrupted biochemical
Table 2 Meta-analysis of statistical differences with appropriate controls in feeding trials
All parameters measured in vivo in GMO toxicity studies Measured by organ
(%)/Total (694-698)
Disturbed in each organ (%)/Total disrupted
parameters (approximately 9%)
Females Males Females Males
Liver 22.9 22.9 30.8 26.1
Kidney 23.7 23.7 26.4 43.5
Bone marrow 29.5 29.5 29.7 22.8
Total for 3 tissues 76.1 76.1 86.9 92.4
Commercialized soybean and maize GMOs were fed to rats and their blood analyses were obtained. The different parameters are classified according to the
tissue [2] to which they are related (e.g., liver, kidney, bone marrow). Of the total parameters measured 76.1% are related to these three organs. The percentages
of significantly different parameters to the controls are called “disrupted parameters.” There are in total 9% of disrupted parameters and, for instance, 43.5% of
these are concentrated in kidneys in males. The bold values are significantly over the parameters measured per organ.
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markers typical of kidney filtration or function problems
[2]. The first effects were not always but sometimes
greater than the ones with non-isogenic maize (called
reference lines), which contain different salts, lipids, or
sugars. Moreover, both results described are different
between males and females; this is quite usual in liver
or kidney pesticide reactions. These facts do not exclude
that such effects can be considered as treatment-related.
Other studies also confirmed effects on kidneys. Tubular
degeneration and not statistically significant enlargement
in parietal layer of Bowman’s capsules were also
observed with GM maize fed rats [16].
Last but not least, a total of around 9% of parameters
were disrupted in a meta-analysis (Table 2). This is
twice as much as what could be obtained by chance
only (generally considered as 5%). Surprisingly, 43.5% of
significant different parameters were concentrated in
male kidneys for all commercialized GMOs, even if only
around 25% of the total parameters measured were kid-
ney-related. If the differences had been distributed by
chance in the organs, not significantly more than 25%
differences would have been found in the kidney. Even
if our own counter analysis is removed from the calcula-
tion, showing numerous kidney dysfunctions [2], around
32% of disturbances are still noticed in kidneys.
Discussion
Need for chronic tests and other tests
Chronic toxicity tests (both with males and females) and
reproductive tests with pregnant females and then with
the developing progeny over several generations (none
of these steps exist at present) are called as a whole the
Toxotest approach (or Risk management test, see
“Details on the new suggested Toxotest approach”). This
could address the long-term physiological or pathologi-
cal relevance of the previous observations. The physiolo-
gical interpretations of 90-day-based effects are
otherwise somewhat limited. These studies should be
complementary to the present regulations or the Safot-
est and the sentinel test suggested by EFSA [1]. The
Toxotest could provide evidence of carcinogenic, devel-
opmental, hormonal, neural, and reproductive potential
dysfunctions, as it does for pesticides or drugs. Addi-
tionally, it is obvious that the 90-day-long trials on
mature animals performed today cannot scientifically
replace the sensitivity of developmental tests on neo-
nates. A good example is the gene imprinting by drugs
that will be revealed only at maturity; this is an impor-
tant subject of current research, and many findings have
been reported for some chemicals such as bisphenol A
[26,27]. Even transgenerational effects occur after epige-
netic imprinting by a pesticide [28]. These effects cannot
be detected by classical 90-day feeding trials and will be
visible after many decades by epidemiology in humans if
any, as illustrated in the case of diethylstilbestrol, which
induced female genital cancers among other problems
in the second generation [29]. The F3 multigenerational
study for a GMO (Table 1) was too rarely performed.
This is why, because of the number of parameters dis-
rupted in adult mammals within 90 days, the new
experiments should be systematically performed to pro-
tect the health of billions of people that could consume
directly or indirectly these transformed products.
The acute toxicity approach (less than a month of
investigations on rodents with high doses) may give
effects which are more proportional to the dose, as it
might correspond to a rapid poisoning of the animals,
generally with force-fed experiments. However, for
many pesticide studies in the scientific literature, some
long-term side effects of pesticides at environmental
doses are described, which are not apparent in short-
term experiments [30]. Classical toxicology is quite
often based on the concept of revealing linear dose-
responses as defined by Paracelsus, which generally fails
to evidence U or J curves observed after hormonal sex-
specific disruptions. Moreover, the effects of mixtures
are also neglected in long-term studies, when supposed
active principles of pesticides are not assessed with their
adjuvants, which also are present as residues in GMOs.
Such pesticides may have the capacity to disrupt the
“cell web”, i.e., to interfere with a signaling pathway, and
this could be unspecific. For instance Roundup is
known to disrupt the EPSPS in plants, but is also
known to interact with the mammalian ubiquist reduc-
tase [21] common and essential to cytochromes P450, a
wide class of detoxification enzymes. The so-called
Roundup active principle, glyphosate, acts in combina-
tion with adjuvants to increase glyphosate-mediated
toxicity [21,31], and this may apply to other environ-
mental pollutants [22]. Moreover, all new metabolites in
edible Roundup ready GMOs, as acetyl-glyphosate for
the new GAT GMOs, have not been assessed for their
chronic toxicity [11], and we consider this as a major
oversight in the present regulations.
Therefore, as xenobiotic effects are complex, the
determination of their toxic effects cannot be deter-
mined using a single method, but rather converging
pieces of evidence. In GMO risk assessment, the proto-
cols must be optimized to detect side effects, in particu-
lar for herbicide-treated GM plants. These cannot be
reduced to GM assessment on one side and herbicide
residues with any diet on the other side, but unfortu-
nately this has been the case, and this approach has
been promoted up to now by regulatory authorities.
In fact, it is impossible, within only 13 weeks, to con-
clude about the kind of pathology that could be induced
by pesticide GMOs and whether it is a major pathology
or a minor one. It is therefore necessary to prolong the
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tests, as suggested by EFSA, since at least one third of
chronic effects visible with chemicals are usually new in
comparison to the ones highlighted in subchronic stu-
dies [1]. The so-called Toxotests, which are supposed to
include the studies of chronic pathologies in particular,
should be performed on three mammalian species, with
at least one non-rodent, similar to the type of rodents
used for pesticides and drugs. However, the chronic
feeding tests for GMOs cannot be based on the no
observed adverse effect level, nor on the lowest observed
adverse effect level approach, as in classical toxicology.
There are several reasons for that. There is not only one
chemical, but also several unknown metabolites and
components, in Roundup tolerant varieties for instance,
and therefore toxicity is enhanced thanks to the fact
that they are mixed together. There is also no possibility
of increasing the doses of GMOs in an equilibrated diet
over an acceptable level. The diets should be rather
representative of an equilibrated diet with GMOs like it
could be the case in a real population in America. To
prolong 90-day subchronic tests with three normal
doses of GM in the diet (11%, 22%, 33% for instance) is
the solution.
Sex- or dose-specific pathological effects are common
When there is a low or environmental dose impregna-
tion of the feed (with a pesticide GM plant for instance),
the chronic effects could be more differentiated accord-
ing to the sex, the physiological status, the age, or the
number of intakes over such and such a period of time
in the case of a drug. These parameters (chronic intake,
age of exposure, etc.) are more decisive for pathologies
like cancers, than the actual quantity of toxin ingested
in one intake. This is in part because the liver, kidney,
and other cytochrome P450-rich organs are concerned
for long-term metabolism and detoxification, and this
phenomenon is hormone dependent. It is also due to
the process of carcinogenesis or hormone-sensitive pro-
gramming of cells [32]. The liver for instance is a sex
differentiated organ as far as its enzymatic equipment is
concerned [4]. An effect in subchronic or chronic tests
cannot be disregarded on the rationale that it is not lin-
ear to the dose (or dose-related) or not comparable in
genders. This would not be scientifically acceptable.
However, this reasoning was adopted both by companies
and EFSA for several GMOs, as underlined by Doull
et al. [33]. Indeed, most xenobiotics or pollutants may
have non-linear effects, and/or may have sex- and age-
specific impacts.
One of the pivotal requirements for regulators nowa-
days, in order to interpret a significant difference as bio-
logically relevant, is to observe a linear dose-response.
This allows them to deduce a causality. However, this
dose-response cannot be studied with only two points,
which is nonetheless the case for all major commercial
GMOs today, which are given in the diet in 11% and
33% concentrations only, in subchronic tests. This is
true overall if no preliminary data has been obtained to
choose the given doses, which is the case in regulatory
files. As we have already emphasized, most of pathologi-
cal and endocrine effects in environmental health are
not directly proportional to the dose, and they have a
differential threshold of sensitivity in both sexes [34].
This is, for instance, the case with carcinogenesis and
endocrine disruption.
Improving the knowledge on impacts of modified Bt
toxins
One of the interpretations of the side effects observed
(Tables 1 and 2) would be that the insecticide toxins in
maize lines may have more pleiotropic or specific actions
than originally supposed. The toxins could generate parti-
cular metabolites, either in the GM plant or in the animals
fed with it. The Bt toxins in GMOs are new and modified,
truncated, or chimerical in order to change their activities/
solubility in comparison to wild Bt. For instance, there is
at least a 40% difference between the toxin in Bt176 and
its wild counterpart [10]. None of the modified Bt toxins
have been authorized separately for food or feed, neither
has the wild Bt, and neither have they been tested by
themselves on animal or human health to date. Even if
some studies were performed, the receptors have not been
cloned and the signaling pathways have not been identified
as yet, nor required for authorizations, and the metabolism
of these proteins in mammals are unknown [35]. Thus, the
argument about “safe use history” of the wild Bt protein
(not designed for direct consumption, in contrast to sev-
eral GMOs) cannot, on a sound scientific basis, be used
for direct authorizations of the above-cited GM corns,
overall without in vivo chronic toxicity tests (or Toxotest
approach), as it is requested for a pesticide. Some
improvements may even be included with regard to pesti-
cide legislation, since these human modified toxins consid-
ered as xenobiotics are continuously produced by the
plants devoted to consumption.
The proteins usually compared (modified Bt toxins
and wild ones) are not identical, and the tests on
human cells of Bt proteins are not performed nor are
they requested by authorities. Their stability has been
assessed in vitro, and GM insecticide toxins are never
fully digested in vivo [36]. If some consumers suffer
from stomach problems or ulcers, the new toxins will
possibly act differently; the digestion in children could
be affected too; however, these GMOs could be eaten
anywhere and all proteins are never fully decomposed in
amino acids by the digestive tract.
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Details on the new suggested Toxotest approach
The suggested Toxotest would basically include an
extension of the existing 90-day tests, but with at least
three doses plus controls (0%, 11%, 22%, 33% GMOs for
instance; today the equilibrated diets tested contain 0%,
11%, and 33% GMOs in the best regulatory tests). The
purpose would be to characterize scientifically the dose-
response approach. The latter cannot be taken seriously
with only two GM doses. The final goal is the best
health protection for the population without really pos-
sible clinical trials, in our case for practical and ethical
reasons. There is also no epidemiological follow-up for
lack of traceability and labeling in GM-producing Amer-
ican countries. In addition, the fact that the Toxotest
includes the best possible toxicological approach will
also be in favor of the biotechnology economy and the
European Community because it is more expensive to
address an issue concerning a whole population after-
wards, rather than to work with laboratory animals
beforehand; it is also more ethical to work on rats and
other mammalian experiments, in order to get the rele-
vant information, rather than to give pesticide plants
directly to humans on a long-term basis.
As previously underlined, the health effects such as
those suggested in Table 2 (if any, are revealed by
adapted studies, such as Safotests or Toxotests), could
only be due to two possibilities:
Firstly, the side effects may be directly or indirectly
due to a pesticide residue and/or its metabolites. The
direct effect is about the pesticide effect on the consu-
mer, and the indirect one is about a metabolism disrup-
tion that it has provoked within the plant first. This
could not be visible by a detailed compositional analysis,
such as the one performed to be assessed by a substan-
tial equivalence study. This concept is not a well-defined
one (how many cultivations of crops, over how many
years, under which climate, and to measure what precise
parameters).
Secondly, the pathological signs may be due to the
genetic transformation itself, its method provoking
either insertional mutagenesis or a new metabolism by
genetic interference. This is the reason why separating
intended effects (the direct genetic trait consequence
itself) from unintended effects (linked to biotechnology,
e.g., insertional mutagenesis), such as spiking the control
diet with the purified toxin in the Toxotest approach, is
clearly inadequate. It could work in the case of a direct
action of the toxin in mammals, but conversely one
could not conclude, between an insertional mutagenesis
and a specific metabolic action in the plant due to the
toxin. However, this is more a research question about
the mode of genesis of an effect on health, and new
research avenues could be, for instance, to compare the
GM diet with or without herbicide treatment in long-
term tests with the isogenic control diet including herbi-
cide residues added. This is only necessary for the
understanding of the potential signs of toxicity and not
for a conclusion of the Safotest or the Toxotest, which
would rather suggest, if positive, excluding immediately
the corresponding GMO from food and feed.
Improvement of statistical analysis
A serious experimental design is based on a proper
choice of the groups, with only one question studied per
experiment if possible, and balanced sample sizes. In
several authorized GMOs, the sample sizes appear
inadequate in 90 days: ten animals per group for the
measurement of biochemical parameters out of 20, as
performed by the major stakeholders, and accepted by
EFSA for MON863, MON810, or NK603 for instance.
This is too limited a size to ensure that parametric sta-
tistical methods used by the company are reliable.
Moreover, an important discrepancy between GMO-
treated rats (40 measured out of 80) and the total
number of animals (400) renders more difficult the evi-
dencing of relevant effects, and confusion factors are
brought in at the same time with six different reference
diets in addition to the two normal control groups as
performed in three commercialized GMOs at least [5,6].
This introduces new uncontrolled sources of variability
about the effects of the diets and new unnecessary ques-
tions not relevant to the GMO safety. The representa-
tion of a standard diet with multiple sources could have
been studied with only one control group of the same
size than the GMO group, eating a mix of six different
regular non-GM diets.
Several questions have been raised by companies and
authorities as well as comments on statistically signifi-
cant effects that would supposedly not be biologically
meaningful. A subjective part is introduced at this level
because it is necessary to take into account the context
and the general and detailed knowledge of toxicology
and endocrine disruption, as EFSA underlines. This
might be highly expert dependent. This is why, to avoid
or prevent any misunderstanding, we suggest, in addi-
tion to a new statistical approach based on classical
methods, to analyze the 90-day tests, even with control
and reference diets called the “SSC method” (according
to the initials of the authors in [2]).
Briefly, following the necessity to model and analyze
the growth curves, multivariate data analysis and data
mining of all parameters can be used to correlate, clus-
ter, and select meaningful variables. This kind of
approach is not performed at all today. Thereafter, the
detailed comparison between GM-treated and control
groups, fed with the near isogenic line (because the real
isogenic line does not often exists anymore), will neces-
sarily be followed by the study of specific diet effects,
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when there are non-substantially equivalent diets for
reference groups. For that purpose, the controls will be
first compared using multivariate inference with refer-
ence groups, and thereafter, similarly GMO-treated
groups with reference groups. The significant differences
linked to the GMO and/or the composition of the diet
will be classified according to organ and function. The
results will appear more clearly than with the simple
statistics accepted today by the authorities (that is, com-
parison of the highest GM dose group with the mean
value of all six control groups), and will reveal in addi-
tion new information, as it can be demonstrated.
As recommended by EFSA, an appropriate and rele-
vant statistical analysis is crucial. It should follow the
following series of steps, allowing the use of several
methods depending on the questions raised:
• Obtaining and modeling the growth curves and feed
consumption, assessed by non-linear regression, vali-
dation, and statistical comparisons in order to test if
the curves are significantly different, thus taking into
account individual variability. This necessitates the
use of time series analysis, selection models, and non-
parametric tests, Akaike Information Criteria and
related methods. Water consumption should also be
an important factor to follow-up and therefore better
understand kidney and urine data.
• The study of dose-response predictions using non-
linear regression should be the goal, but the only
two doses generally used in these tests do not make
it possible to evidence linearity as we indicated.
Moreover, in the cases where there are not dose-
related trends or relationships using the two doses
mentioned, the absence of linear dose-response
curves cannot be a reason to neglect the effects. For
instance, as previously cited, U or J curves may be
characteristic of endocrine effects [37], and spiky
irregular curves may be detected in carcinogenesis.
• Simultaneous analysis of all observed variables:
multivariate data analysis, principal component ana-
lysis, correlations analysis, factorial analysis and
clustering
• Multivariate comparisons of the different variables:
hypothesis testing, multiple ways ANOVA, MAN-
OVA, and others to determinate if the groups differ
relative to the different questions: specific GMO
effect or diet effect per se. To evidence a detail,
when comparing two mean values, SEM should be
calculated to determine confidence intervals; how-
ever, SD have been used up to now by the company
for MON863 and NK603 files for instance.
Apart from empirical curves in some instances,
ANOVA and univariate hypothesis testing only the
GMO effect, none of the other statistical approaches is
currently used nor requested by the authorities.
Human tests and post-market monitoring
For the record, it must be said that very few tests on
humans have been carried out up to now. Moreover,
epidemiological studies are not feasible in America,
since there is no organized traceability of GMOs any-
where on the continent, where, by far, most of edible
GMOs are cultivated (97%). As a consequence, a post-
market monitoring (PMM) is offered to the population.
The Cartagena Biosafety Protocol identifying GMOs at
the borders of a country has now been signed by over
150 countries, including the member states of the Eur-
opean Union. PMM may have some value in detecting
unexpected adverse effects. It could therefore be consid-
ered as a routine need. This approach makes it possible
to collect information related to risk management. It
can be relied upon as a technique for monitoring
adverse events or other health outcomes related to the
consumption of GM plant-derived foods, provided that
the Toxotest approach, together with the SSC method,
should have already been applied. The PMM should be
linked with the possibility of detecting allergenicity reac-
tions to GMOs in routine medicine, thanks to the very
same routine cutaneous tests that should be developed
prior to large-scale commercialization. A screening of
serum banks of patients with allergies could be also put
forward in order to search for antibodies against the
main GMOs and not only their transgenic proteins,
since they may induce secondary allergenic metabolites
in the plant not visible in the substantial equivalence
study.
The traceability of products from animals fed on
GMOs is also crucial. The reason for this is because
they can develop chronic diseases which are not utterly
known today. Such possible diseases could be linked to
the hepatorenal toxicity observed in some GMO-related
cases (Table 1).
Moreover, labeling animals fed on GMOs is therefore
necessary because some pesticide residues linked to
GMOs could pass into the food chain and also because
nobody would want to eat disabled or physiologically
modified animals after long-term GMOs ingestion, even
if pesticides residues or DNA fragments are not toxic
nor transmitted by themselves.
Conclusion
Transcriptomics, proteomics and other related methods
are not ready yet for routine use in the laboratories, and
moreover they may be inappropriate for studying toxi-
city in animals, and could not in any way replace in vivo
studies with all the physiological and biochemical para-
meters that are measured with organs weight,
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appearance, and histology. By contrast, afterwards, new
approaches could well help to explain pathological
results or action mechanisms of pesticides present in
the GM plants or GM-fed animals, if found.
To obtain the transparency of raw data (including rat
blood analyses) for toxicological tests, maintained illeg-
ally confidential, is crucial. It has also become crucial to
apply objective criteria of interpretation like the criteria
described here: sex-specific side effects or non-linear
ones. Such data can be put online on the EFSA website
with a view to provide a fuller review to the wider scienti-
fic community, and in order to better inform the citizen
to make biotechnologies more socially acceptable. Since
fundamental research is published on a regular basis, it
should be the same for this kind of applied research on
long-term health effects, as suggested by the CE/2001/18
and the corresponding 1829/2003 regulations.
We can conclude, from the regulatory tests performed
today, that it is unacceptable to submit 500 million Eur-
opeans and several billions of consumers worldwide to
the new pesticide GM-derived foods or feed, this being
done without more controls (if any) than the only
3-month-long toxicological tests and using only one
mammalian species, especially since there is growing
evidence of concern (Tables 1 and 2). This is why we
propose to improve the protocol of the 90-day studies
to 2-year studies with mature rats, using the Toxotest
approach, which should be rendered obligatory, and
including sexual hormones assessment too. The repro-
ductive, developmental, and transgenerational studies
should also be performed. The new SSC statistical
method of analysis is proposed in addition. This should
not be optional if the plant is designed to contain a pes-
ticide (as it is the case for more than 99% of cultivated
commercialized GMOs), whilst for others, depending on
the inserted trait, a case-by-case approach in the method
to study toxicity will be necessary.
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